Provided by Tiger Trade Technology Pte. Ltd.

IT Tech Packaging Inc

0.1620
+0.01409.46%
Volume:2.84M
Turnover:431.39K
Market Cap:2.75M
PE:-0.19
High:0.1643
Open:0.1506
Low:0.1410
Close:0.1480
52wk High:0.3900
52wk Low:0.1310
Shares:16.97M
Float Shares:16.42M
Volume Ratio:27.15
T/O Rate:17.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8619
EPS(LYR):-0.9779
ROE:-6.92%
ROA:-3.36%
PB:0.02
PE(LYR):-0.17

Loading ...

Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders

GlobeNewswire
·
Jun 11

Climb Bio Reports Encouraging Early Budoprutug ITP Data

TIPRANKS
·
Jun 11

Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026

GlobeNewswire
·
Jun 11

Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases

GlobeNewswire
·
Jun 10

argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogren’s Disease at EULAR 2026

GlobeNewswire
·
Jun 03

Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib

GlobeNewswire
·
Jun 01

InnoCare Pharma Gets Acceptance for ITP New Drug Application; Shares Up 3%

MT Newswires Live
·
May 29

Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures

GlobeNewswire
·
May 28

InnoCare’s ITP Drug Filing for Orelabrutinib Accepted by China Regulator

TIPRANKS
·
May 28

Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia

GlobeNewswire
·
May 26

Climb Bio to Present on CLYM116 and Budoprutug Programs at European Renal Association (ERA) Congress 2026

GlobeNewswire
·
May 26

US$800 million commitment achieved by FAST-P initiative Green Investments Partnership

Lin Daoyi
·
May 20

Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress

GlobeNewswire
·
May 14

IT Tech Packaging delays Q1 Form 10-Q filing, seeks 5-day extension

Reuters
·
May 14

Press Release: Bionano Reports First Quarter 2026 Results and Provides a Business Update

Dow Jones
·
May 14

Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates

GlobeNewswire
·
May 07

argenx Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 07

Bionano Announces Leadership Transition

GlobeNewswire
·
May 07

Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025

GlobeNewswire
·
May 05

Climb Bio Hosts Budoprutug R&D Spotlight Event Highlighting Topline Subcutaneous Formulation Data, Broad B-Cell Mediated Disease Opportunity, and Upcoming Data Readouts

GlobeNewswire
·
May 05